HYDROmorphone HCl syringe recalled due to labeling mix-up
STAQ Pharma is recalling HYDROmorphone HCl PF syringes (lot 21104221A) that were incorrectly labeled as Morphine Sulfate PF. The mislabeling affects approximately 905 syringes distributed in Colorado, Ohio, and Texas.
What this means for you
Illness, injury, or structural failure has been reported. Stop using the product immediately and contact the manufacturer for a refund or repair.
Our severity reasoning: This recall is classified as FDA Class I by the agency. The labeling error creates a risk of medication administration error involving opioid analgesics, which could result in serious patient harm. Per the rubric, FDA Class I recalls with risk of serious injury receive a severity score of 4.
Plain-English summary
STAQ Pharma, Inc. is recalling a limited number of HYDROmorphone HCl PF 10 mg/50 mL (0.2 mg/mL) single-dose syringes due to a labeling error. The affected syringes were incorrectly labeled as Morphine Sulfate PF and carry lot number 21104221A with an expiration date of 05-22-2022.
Approximately 905 syringes are affected by this recall. The product was distributed to Colorado, Ohio, and Texas.
Healthcare facilities and providers who have received this product should stop use immediately and contact STAQ Pharma, Inc. for proper product identification and replacement. Patients receiving treatment with these syringes should consult their healthcare provider regarding any concerns.
The recalled product
- Product
- HYDROmorphone HCl PF 10 mg/50 mL (0.2mg/mL) in NaCl, 50 mL in 50 mL Single Dose Syringe, Rx only, STAQ Pharma, Inc., Denver, CO 80239, NDC: 73177-0104-05.
- Manufacturer
- STAQ Pharma, Inc.
- Hazard
- labeling-error
- medication-mix-up
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (2)
- Lot Number: 21104221A
- Expiration date: 05-22-2022
Distribution
Distributed in 3 states:
- CO
- OH
- TX
Related recalls
Same category
- CriticalWarfarin Tablets Recalled After Mix-Up Between 2.5 mg and 5 mg Strengths
FDA (Drugs) · 2026-07-21
- ModerateFDA Recalls Pred Mild Ophthalmic Suspension Due to Failed Stability Specifications
FDA (Drugs) · 2026-06-03
- ModerateNicotine Transdermal System Patches Recalled for Oxidative Impurity Specification Failure
FDA (Drugs) · 2026-06-03
- HighLiraglutide Injection Recalled Due to Particulate Matter in Cartridges
FDA (Drugs) · 2026-05-27
- LowPrimidone Tablets Recalled for Cross-Contamination with Acemetacin
FDA (Drugs) · 2026-05-27